(IN BRIEF) CompuGroup Medical SE & Co. KGaA (CGM), a leading e-health provider, has announced the appointment of two renowned digitization experts in the German healthcare system. Max Müller has assumed leadership of the CLICKDOC & m.Doc business area, while … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, Management, News, Technology
Tagged appointment, CompuGroup Medical, Digitization Experts, Dr. Ulrich Thomé, Germany, healthcare sector, Jan Wemmel, leadership, Max Müller
(IN BRIEF) Aviva collaborates with fitness icon Joe Wicks and Strava to launch the #MoveWithAviva challenge, aiming to inspire individuals across the nation to prioritize their health and wellness. In response to findings revealing common barriers to exercise, such as … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Insurance, Investment, Management, News, United Kingdom
Tagged Aviva, Dr Suba M, exercise, health, Joe Wicks, partnership, Strava App, wellbeing, wellness
(IN BRIEF) The University of Helsinki has initiated a doctoral education pilot, sponsored by the Finnish Ministry of Education and Culture, offering three-year positions for doctoral researchers. With 236 vacancies across 11 sectoral pilots, the application period runs until April … Read the full press release
(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been acknowledged by the US FDA for treating adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who have received prior systemic … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Biologics License Application (BLA), Breast Cancer Treatment, Daiichi Sankyo, datopotamab deruxtecan, Japan, Ken Takeshita, partnership, safety, Susan Galbraith, sustainability, US FDA
(IN BRIEF) AstraZeneca and Sanofi celebrate the approval of Beyfortus (nirsevimab) in Japan by the Ministry of Health, Labour, and Welfare for preventing lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in neonates, infants, and children entering … Read the full press release
Posted in Business, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Beyfortus, Dr. Hiroyuki Moriuchi, France, Iskra Reic, Japan, LRTD, partnership, prophylaxis, respiratory syncytial virus, safety, Sanofi, sustainability
(IN BRIEF) AstraZeneca announces the approval of Truqap (capivasertib) in combination with Faslodex (fulvestrant) by the Japanese Ministry of Health, Labour, and Welfare (MHLW) for treating adult patients with unresectable or recurrent hormone receptor-positive, HER2-negative breast cancer. The approval, based … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Breast Cancer Treatment, Dave Fredrickson, Faslodex, Japan, Masakazu Toi, MHLW, safety, Truqap
(IN BRIEF) A recent survey conducted by Sony Healthcare Europe indicates that 95% of surgeons and oncologists across Europe experienced negative mental health issues in 2023, a level comparable to the aftermath of the pandemic in 2021. The survey of … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Science, Technology, United Kingdom
Tagged depression, European, Ludger Philippsen, mental health, Oncologists, Sony, surgeons
(IN BRIEF) A recent study by the University of Helsinki and the University of Tampere suggests that Lewy body disease, the second most common brain degenerative disorder after Alzheimer’s, may be more prevalent in middle-aged individuals than previously believed. Utilizing … Read the full press release
(IN BRIEF) Poet Yrsa Daley-Ward collaborates with Sainsbury’s and Comic Relief to illuminate the untold struggles of individuals facing food insecurity in the UK. Through “Unspoken Words,” a collection of poems inspired by real-life stories from the Bonny Downs food … Read the full press release
(IN BRIEF) Fraunhofer experts are at the forefront of developing AI-driven systems to revolutionize healthcare, presenting their latest advancements at the DMEA 2024 trade show. These innovations span various areas, including diagnostics, surgery planning, telemedicine, and data management. From AI-based … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Media, News, Science, Technology
Tagged AI, DMEA 2024, Fraunhofer, Healthcare, healthcare IT, innovations
(IN BRIEF) DPI, BII, and the EBRD have reached a binding agreement to fully exit their investment in KELIX bio, a pan-African biopharmaceutical platform, through its acquisition by Mubadala Investment Company. Founded in 2020, KELIX bio has rapidly grown to … Read the full press release
Posted in Banks, Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acquisition, Africa, Alhadi Alwazir, British International Investment (BII), Development Partners International (DPI), EBRD, Essam Farouk, Frederic Lucenet, Hocine Sidi Said, KELIX bio, Mubadala, partnership, pharmaceuticals, Samir Abhyankar, Sofiane Lahmar, sustainability
(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk’s acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to EUR 1.025 billion. Based in Hannover, Germany, Cardior specializes in RNA-based therapeutics for cardiovascular diseases, focusing initially on heart failure. … Read the full press release
Posted in Business, Denmark, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Cardior Pharmaceuticals, Christoph Broja, Claudia Ulbrich, Denmark, EQT, EQT Life Sciences, Germany, Heart Diseases, Novo Nordisk, partnership, Professor Thomas Thum, RNA Therapies, sustainability
(IN BRIEF) Ultomiris (ravulizumab-cwvz) has gained approval from the FDA as the inaugural long-acting C5 complement inhibitor for treating adult patients with anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD). The approval, based on the CHAMPION-NMOSD Phase III trial’s … Read the full press release
Posted in Business, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AQP4 Ab+, AstraZeneca, Marc Dunoyer, neuromyelitis optica spectrum disorder (NMOSD), safety, Sean J. Pittock, treatment, Ultomiris, USFDA
(IN BRIEF) Look Good Feel Better, in partnership with England Netball, organized its Annual Charity Netball Tournament at the University of Warwick, raising over £32,000 for individuals undergoing cancer treatment. The event, attended by 240 netball players, featured 26 teams … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Non Profit, Science, Sports, Technology, United Kingdom
Tagged Ama Agbeze, Annual Charity Netball Tournament, Ash Dekker, Cancer, charity, England Netball, Lizzie Cooper, Look Good Feel Better, Mark Hyndman, Millie Sanders, partnership, sports, University of Warwick
(IN BRIEF) Researchers at the University of Southampton have made significant progress towards developing a blood test capable of identifying millions of individuals unknowingly spreading tuberculosis (TB). By analyzing blood markers, the study identified a set of six proteins highly … Read the full press release
(IN BRIEF) New research reveals that women experience disruptions in sleep patterns and heightened feelings of anger in the days leading up to their period, shedding light on the intricate relationship between menstrual cycles, emotions, and sleep. Conducted by the … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, News, Science, United Kingdom
Tagged Dr Jessica Meers, Dr Jo Bower, Menstrual Cycle, Sleep and Emotions, University of East Anglia, WOMEN
(IN BRIEF) A service evaluation conducted by the University of East Anglia unveils a groundbreaking initiative where GPs utilized cameras to photograph skin complaints, sending high-resolution images to dermatologists for review. With over 3,000 patients involved, the innovative service significantly … Read the full press release
(IN BRIEF) Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting marketing authorization for Fabhalta® (iptacopan) for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH) who … Read the full press release
(IN BRIEF) Breakpoint Therapeutics GmbH, a company focused on developing drugs targeting the DNA Damage Response (DDR), has nominated its first preclinical development candidate, BTX-011, an inhibitor of polymerase theta (Pol θ / POLQ), for the treatment of solid tumors. … Read the full press release
(IN BRIEF) Evonik has been honored with the Asia-Pacific Bioprocessing Excellence Award (ABEA) for the second consecutive year, specifically in the category of Best New Bioprocessing Supplier Award: Upstream Processing, for its Cell Culture Solutions portfolio. As a crucial component … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?